Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,156 | 96,942 | 113,788 | 66,666 | 46,007 |
| Marketable Securities | 90,116 | 123,763 | 33,403 | 12,893 | 29,196 |
| Receivables | 65,639 | 53,976 | 45,689 | 50,772 | 57,266 |
| Inventories | 76,424 | 75,333 | 75,086 | 86,194 | 65,935 |
| Income taxes - deferred | 13,460 | 13,775 | 13,934 | 14,239 | 12,738 |
| Other current assets | 8,797 | 6,800 | 6,114 | 4,812 | 4,688 |
| TOTAL | $301,592 | $370,589 | $288,014 | $235,576 | $215,830 |
| Non-Current Assets | |||||
| PPE Net | 62,630 | 45,224 | 49,455 | 49,215 | 45,661 |
| Investments And Advances | 19,687 | 35,082 | 15,572 | 21,016 | 0 |
| Intangibles | 124,494 | 61,766 | 56,157 | 55,208 | 0 |
| Other Non-Current Assets | 5,834 | 9,214 | 8,228 | 12,092 | 74,305 |
| TOTAL | $212,645 | $151,286 | $129,412 | $137,531 | $119,966 |
| Total Assets | $514,237 | $521,875 | $417,426 | $373,107 | $335,796 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,723 | 19,160 | 9,427 | 10,887 | 13,714 |
| Accrued Expenses | 55,539 | 49,075 | 43,395 | 38,890 | 39,908 |
| Other current liabilities | 2,785 | 2,250 | N/A | N/A | N/A |
| TOTAL | $99,952 | $100,345 | $70,274 | $71,377 | $74,049 |
| Non-Current Liabilities | |||||
| Long Term Debt | 519 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 10,153 | 8,275 | 7,662 | 13,220 | 11,955 |
| Other Non-Current Liabilities | 1,403 | 2,230 | 46 | 0 | 0 |
| TOTAL | $16,625 | $8,238 | $6,179 | $N/A | $N/A |
| Total Liabilities | $116,577 | $108,583 | $76,453 | $71,377 | $74,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,636 | 138,813 | 136,095 | 135,776 | N/A |
| Common Shares | 4,522 | 4,439 | 4,233 | 4,135 | 4,025 |
| Retained earnings | 318,682 | 240,350 | 183,260 | 137,871 | 100,251 |
| Other shareholders' equity | 11,639 | 4,254 | -2,868 | -7,159 | -5,443 |
| TOTAL | $397,660 | $413,292 | $340,973 | $301,730 | $261,747 |
| Total Liabilities And Equity | $514,237 | $521,875 | $417,426 | $373,107 | $335,796 |